XENO (Xeno Transplants) EBITDA Margin %: 0.00% (As of Mar. 2008)


What is Xeno Transplants EBITDA Margin %?

Xeno Transplants XENO EBITDA Margin % is 0.00% as of Mar. 2008.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Xeno Transplants's EBITDA for the three months ended in Mar. 2008 was $-0.11 Mil. Xeno Transplants's Revenue for the three months ended in Mar. 2008 was $0.00 Mil. Therefore, Xeno Transplants's EBITDA margin for the quarter that ended in Mar. 2008 was 0.00%.

Xeno Transplants  (OTCPK:XENO) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Xeno Transplants EBITDA Margin % Related Terms

Xeno Transplants EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Xeno Transplants's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Xeno Transplants EBITDA Margin % Chart

Xeno Transplants Annual Data
Trend Jun05 Jun06 Jun07
EBITDA Margin %
0.00 0.00 0.00

Xeno Transplants Quarterly Data
Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

XENO vs PRTX, GWSN, HSTC: EBITDA Margin % Comparison

For the Biotechnology subindustry, Xeno Transplants's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Xeno Transplants EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Xeno Transplants's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Xeno Transplants's EBITDA Margin % falls into.


Xeno Transplants EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Xeno Transplants's EBITDA Margin % for the fiscal year that ended in Jun. 2007 is calculated as

EBITDA Margin %=EBITDA (A: Jun. 2007 )/Revenue (A: Jun. 2007 )
=-0.128/0
= %

Xeno Transplants's EBITDA Margin % for the quarter that ended in Mar. 2008 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2008 )/Revenue (Q: Mar. 2008 )
=-0.11/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
Xeno Transplants (XENO) has a EBITDA Margin % of 0.00% as of Mar. 2008. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Xeno Transplants and its competitors.
Is Xeno Transplants' EBITDA Margin % too high?
Xeno Transplants' current EBITDA Margin % is 0.00%.
How does Xeno Transplants' EBITDA Margin % compare to PRTX and GWSN?
Xeno Transplants' EBITDA Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Xeno Transplants and its competitors. Xeno Transplants's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xeno Transplants stock overvalued right now?
Xeno Transplants (XENO) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Xeno Transplants (XENO), the current EBITDA Margin % is 0.00% as of Mar. 2008. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Xeno Transplants Business Description

Address 143 Gardner Road, Brookline, MA, USA, 02445
Xeno Transplants Corp is a bio-technology research and development company, which intends to develop therapeutic applications of organs and cells derived from genetically engineered pigs as a transplant alternative to limited human donor sources.